News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Sanofi is planning to expand the market for its best-selling anti-inflammatory drug Dupixent, used to treat COPD, also known as ‘smokers lung’, after a successful second phase 3 trial.
1nhaler, a Scotland-based drug delivery device developer, has raised £2 million to develop its single-use dry powder inhaler (DPI).
It is five years this month since a ground-breaking change in UK healthcare history happened – with doctors being able to prescribe cannabis-based medicines for the first time.